Use of short-term in vitro tumour colony forming *assays (in agar, agarose, or methyl cellulose media) for assessing anticancer drug effects and for screening for new anticancer agents has been a popular area of oncologic research since the original publications by Salmon's group in 1977 -1978 (Hamburger & Salmon, 1977 Salmon et al., 1978) . In the last seven years, more than 700 publications have described the general use of soft agar tumour colony forming assays for quantitation of cancer cell proliferation and anticancer drug effects in vitro (Human Tumor Cell Cloning Bibliography, 1984) . Promising reports of good correlation between results of in vitro soft agar colony forming assays and patients' clinical response or resistance to chemotherapeutic agents have been published (Salmon et al., 1978; Alberts et al., 1980; Von Hoff et al., 1981 , 1983 . Despite this extensive international experience, major questions remain about the biologic significance, technical performance and clinical utility of such assays (Lancet Editorial, 1982; Lieber & Kovach, 1982; Selby et al., 1983; Agrez et al., 1982a; Lieber, 1983) .
The Mayo Clinic has had an intense interest in studying human tumour colony forming assays over the past 5 years. To date, this laboratory has studied over 6,200 different specimens of primary Correspondence: M.M. Lieber Received 22 April 1985. human cancers in soft agar colony formation assays similar to that described by Salmon and colleagues.
This extensive experience has generated concern about technical problems which occur in the performance of soft agar colony forming assays using samples of cells isolated from primary human tumours; publications on this topic have appeared in this journal previously (Agrez et al., 1982a;  Alley & Lieber 1984 & Lieber , 1985 . Consequently, it was of interest to investigate whether the use of a different way of assessing cell proliferation and drug effects in such soft agar tumour colony forming assays might be as effective or more effective than simply optically counting the number of colonies formed. Use of a thymidine incorporation measurement of cell proliferation applied to soft agar culture dishes appeared relevant because promising experience with such a method had been reported by several groups (Friedman and Glaubiger, 1982; Tanigawa et al., 1982; Shoemaker et al., 1982; Johnson and Glaubiger, 1983; Rupniak et al., 1983; Sondak et al., 1984; Ichihashi et al., 1984) .
The present manuscript reports experience in studying drug sensitivities of paired samples of human tumour cells, in a soft agarose colony forming assay, using both a standard computerized optical image analysis colony counting endpoint, and a thymidine incorporation endpoint patterned as closely as possible after the methodology described by Dr. Kern and his group (Tanigawa et al., 1982) . (Agrez et al., 1982b) . ' The control soft agarose cultures received 0.1 ml unsupplemented culture medium and the drug-treated cultures received 0.1 ml drug, both of which were applied on top of the cellular agarose layer. There were 6 dishes per control group and 3 dishes per drugtreated group (continuous drug exposure). The vital stain, 2-(-iodophenyl)-3-(p-nitro-phenyl)-5-phenyl tetrazolium chloride (INT) was obtained from Aldrich Chemical Company. Stock INT at lmgml-l in distilled water was prepared twice a week as described previously (Alley et al., 1982) .
Materials and methods

Continuous
Culture dishes from each group received 1 ml of stock INT at the indicated times and were reincubated at 37°C for a further 24h. The cultures were then stored at 4°C until colony formation was assessed by computerized image analysis (see below) within 48 h.
Assessment of colony sizes and numbers
The number and sizes of viable INT-stained colonies were determined on a 500 mm2 area of each petri dish using a computerized image analyzer, FAS-TT (Omnicon Feature Analysis System, Model II, Bausch & Lomb, Inc.). The Omnicon stem cell program computed the number of standard colonies for a 500 mm2 area that had diameters of 30, 43, 60, 86, 122, or 173 ,im. The mean viable colony count and standard deviation was recorded. A 60,um D control (no drug treatment) colony is a 'standard' size used to measure colony formation in the soft agar colony forming assay for cell line, xenograft and primary tumour cells. (Agrez et al., 1982a) . The number of cells in such a 60pgm D colony is highly variable from tumour to tumour. (Meyskens et al., 1984) .
To determine the numbers of viable 60 gm cellular aggregates present at the time* of drug application ('Day 1 count') in primary and xenograft tumour cultures, INT was applied to a set of triplicate control dishes from all xenograft and primary human tumour specimens immediately following placement into agarose culture. Primary tumour agarose cultures were considered acceptable if: The number of viable colony counts was <25 on Day 1, the number of viable 60 um D images increased by at least 1N fold (minimum of 36) over that determined on Day 1 of incubation (Agrez et al., 1982a) , and the uniformly cytotoxic 'positive control drug' (100ugml-' mercuric chloride) produced a > 70% decrease in 60 gm colony count. plot of data from one xenograft experiment is presented in Figure 3 Figure 5 , Table IV ). The averaged regression line for these experiments suggests a greater sensitivity for detecting drug activity using the thymidine assay (rather than optical colony counting) when an increased number of larger viable cell aggregates is present in the cultures when the drug is first applied.
Primary human tumour specimens Ninety-four primary human carcinoma specimens of various histologic types were studied. Tumour types included: colon (22), kidney (13), endometrium (13), lung (10), ovary (9), breast (5), bladder (3), rectum (3), melanoma (3), omentum (3), small bowel (3), testis (2), brain (2), leiomyosarcoma (abdominal) (1), adrenal gland (1) individual drug tests, Figure 5 , Table III (Twentyman et al., 1984) .
The data also suggest that the presence of an increased number of larger viable cell aggregates (.60pm in diameter) on the day of plating makes the optical counting method less sensitive for detecting drug effects than the thymidine incorporation assay. Since the preparation of cell suspensions from human tumour xenografts and, especially, from primary human cancers, is generally complicated by the presence of small cell aggregates (Agrez et al., 1982a; Umbach & Spitzer, 1983; Alley & Lieber, 1984) ; then use of this or related assays for measuring tritiated thymidine incorporation may prove to be more sensitive and reliable than optical counting for detecting anticancer drug effects in soft agar cultures. 
